SEC 13F Intelligence

Cullen/Frost Bankers, Inc. / LLY

Cullen/Frost Bankers, Inc.’s Eli Lilly & Co Position

Does Cullen/Frost Bankers, Inc. own Eli Lilly & Co (LLY)? Yes — 103.8K shares worth $96M (+1.08% of its 13F portfolio) as of Q1 2026, up from 103.7K shares the prior filed quarter.

Position Value
$96M
Q1 2026
Shares
103.8K
% of Portfolio
+1.08%
Quarters Held
30
currently held

Position History LLY

Reported value by quarter
Q4 ’18: $4MQ4 ’18Q1 ’19: $4MQ2 ’19: $3MQ3 ’19: $3MQ4 ’19: $3MQ4 ’19Q1 ’20: $3MQ2 ’20: $4MQ3 ’20: $15MQ4 ’20: $18MQ4 ’20Q1 ’21: $20MQ2 ’21: $24MQ3 ’21: $25MQ4 ’21: $29MQ4 ’21Q1 ’22: $31MQ2 ’22: $35MQ3 ’22: $36MQ4 ’22: $44MQ4 ’22Q1 ’23: $41MQ2 ’23: $55MQ3 ’23: $62MQ4 ’23: $63MQ4 ’23Q1 ’24: $81MQ2 ’24: $93MQ3 ’24: $91MQ4 ’24: $79MQ4 ’24Q1 ’25: $85MQ2 ’25: $81MQ3 ’25: $79MQ4 ’25: $111MQ4 ’25Q1 ’26: $96Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026103.8K$96M+1.08%
Q4 2025103.7K$111M+1.23%
Q3 2025104.1K$79M+0.92%
Q2 2025103.8K$81M+1.01%
Q1 2025102.8K$85M+1.19%
Q4 2024102.0K$79M+1.08%
Q3 2024102.5K$91M+1.24%
Q2 2024102.9K$93M+1.35%
Q1 2024104.2K$81M+1.20%
Q4 2023108.4K$63M+0.99%
Q3 2023116.1K$62M+1.09%
Q2 2023118.1K$55M+0.94%
Q1 2023120.8K$41M+0.76%
Q4 2022121.1K$44M+0.85%
Q3 2022112.9K$36M+0.83%
Q2 2022109.2K$35M+0.79%
Q1 2022106.5K$31M+0.59%
Q4 2021103.9K$29M+0.55%
Q3 2021107.0K$25M+0.50%
Q2 2021102.4K$24M+0.47%
Q1 2021106.0K$20M+0.43%
Q4 2020105.9K$18M+0.41%
Q3 202099.6K$15M+0.37%
Q2 202023.5K$4M+0.10%
Q1 202023.9K$3M+0.12%
Q4 201924.9K$3M+0.09%
Q3 201926.1K$3M+0.09%
Q2 201927.7K$3M+0.10%
Q1 201928.5K$4M+0.11%
Q4 201831.5K$4M+0.14%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Cullen/Frost Bankers, Inc.’s full portfolio or all institutional holders of LLY.